Canada Pension Plan Investment Board’s Travere Therapeutics TVTX Stock Holding History

Canada Pension Plan Investment Board’s Portfolio TVTX Stock Details TVTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-8,100	Closed	-$241K	–	1872
2026 Q1	$241K	Sell	8,100 -1,000	-11%	-$29.9K	﹤0.01%	1505
2025 Q4	$348K	Buy	+9,100	New	+$296K	﹤0.01%	1452
2024 Q1	–	Sell	-224,000	Closed	-$2.01M	–	1260
2023 Q4	$2.01M	Hold	224,000	–	–	﹤0.01%	840
2023 Q3	$2M	Buy	+224,000	New	+$3.16M	﹤0.01%	766
2022 Q2	–	Sell	-731,000	Closed	-$18.8M	–	1376
2022 Q1	$18.8M	Buy	731,000 +220,000	+43%	+$5.84M	0.03%	398
2021 Q4	$15.9M	Buy	511,000 +53,000	+12%	+$1.49M	0.02%	482
2021 Q3	$11.1M	Buy	458,000 +100,000	+28%	+$1.84M	0.01%	555
2021 Q2	$5.22M	Buy	+358,000	New	+$7.06M	0.01%	637

Other funds holding TVTX

Jupiter Topco New York $245B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Canada Pension Plan Investment Board's TVTX Position: Q2 2026 in Review

Canada Pension Plan Investment Board sold out of Travere Therapeutics (TVTX) in Q2 2026, closing a stake of 8,100 shares — an estimated $241K sold.

Canada Pension Plan Investment Board first reported a position in TVTX in Q2 2021 and held it in 8 quarters. The position peaked at $18.8M in Q1 2022. 320 funds tracked by Wall St. Rank hold TVTX as of Q2 2026.

Canada Pension Plan Investment Board reported no remaining Travere Therapeutics position as of Q2 2026 after selling out during the quarter.
Canada Pension Plan Investment Board sold 8,100 Travere Therapeutics shares in Q2 2026, an estimated $241K.
Canada Pension Plan Investment Board first reported a position in Travere Therapeutics in Q2 2021 and held it in 8 quarters.
Canada Pension Plan Investment Board's Travere Therapeutics position peaked at $18.8M in Q1 2022.
320 funds tracked by Wall St. Rank held Travere Therapeutics as of Q2 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.